Evidence map›Paper›PMID 35616714›Full record

SynthesisEuropean child & adolescent psychiatry2023

A meta-analytic review of the impact of ADHD medications on anxiety and depression in children and adolescents.

Annie Bryant, Hope Schlesinger, Athina Sideri, Joni Holmes, Jan Buitelaar, Richard Meiser-Stedman

Open access · hybridAbstract readMeta-AnalysisReview
In one paragraph

Synthesis in European child & adolescent psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Annie BryantDepartment of Clinical Psychology and Psychological Therapies, University of East Anglia, Norwich, UK.ORCID http://orcid.org/0000-0003-2669-2191
Hope SchlesingerDepartment of Clinical Psychology and Psychological Therapies, University of East Anglia, Norwich, UK.
Athina SideriNorfolk and Suffolk NHS Foundation Trust, Hellesdon Hospital, Drayton High Road, Norwich, UK.
Joni HolmesMRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK.
Jan BuitelaarRadboud University, Houtlaan 4, 6525 XZ, Nijmegen, Netherlands.
Richard Meiser-StedmanDepartment of Clinical Psychology and Psychological Therapies, University of East Anglia, Norwich, UK. r.meiser-stedman@uea.ac.uk.
University of East Anglia · GBMRC Cognition and Brain Sciences Unit · GBNorfolk and Suffolk NHS Foundation Trust · GBRadboud University Nijmegen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anxiety and depression are listed as common side effects for medications licensed for treating ADHD in children and adolescents. This meta-analytic review of randomised controlled trials aimed to explore the effect of medications on symptoms of anxiety and depression in children and adolescents with ADHD. A meta-analytic review of ADHD drug trials in children and adolescents was conducted. Random effects meta-analyses were conducted on anxiety and depression outcomes measured by validated psychological scales or side effect rating scales. Only 11% of eligible trials in this review reported anxiety and/or depression as an outcome or side effect, limiting the conclusions of the meta-analyses. Relative to placebo control, no significant effect of medication was found for symptoms of anxiety or depression in randomised controlled trials of ADHD medication in children and adolescents. This review highlights the systemic lack of mental health outcome reporting in child and adolescent ADHD drug trials. The importance of widespread implementation of standardised measurement of mental health outcomes in future trials is discussed.

Indexed as

Attention Deficit Disorder with HyperactivityAdolescentAnxietyAnxiety DisordersChildDepressionHumansADHDAdolescentsAnxietyChildrenDepressionMental healthPharmacologyRandomised controlled trialsSide effects

Identifiers

PMID35616714
PMCPMC10533622
OpenAlexW4281551611

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.